1662999
Last Update Posted: 2015-05-08
Recruiting has ended
All Genders accepted | 18 Years-45 Years |
42 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants
The purpose of this study is to evaluate whether the pharmacokinetics (body concentrations/metabolism of the drug) of Saxagliptin and Dapagliflozin are affected when they are administered together
Eligibility
Relevant conditions:
Type 2 Diabetes Mellitus
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov